ReviewEuropean urology open science2020

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not.

Otto Hemminki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.